Prediction and Monitoring of Adaptive Radiation Therapy Timing Using Two-dimensional X-ray Image-based Water Equivalent Thickness.

IF 1.6 4区 医学 Q4 ONCOLOGY Anticancer research Pub Date : 2025-01-01 DOI:10.21873/anticanres.17427
Kouta Hirotaki, Shunsuke Moriya, Kento Tomizawa, Masashi Wakabayashi, Atsushi Motegi, Masashi Ito, Takeji Sakae
{"title":"Prediction and Monitoring of Adaptive Radiation Therapy Timing Using Two-dimensional X-ray Image-based Water Equivalent Thickness.","authors":"Kouta Hirotaki, Shunsuke Moriya, Kento Tomizawa, Masashi Wakabayashi, Atsushi Motegi, Masashi Ito, Takeji Sakae","doi":"10.21873/anticanres.17427","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>This study aimed to predict the optimal timing for adaptive radiation therapy (ART) using two-dimensional X-ray image-based water equivalent thickness (2DWET).</p><p><strong>Patients and methods: </strong>Forty patients with oropharyngeal and hypopharyngeal cancer underwent Computed Tomography (CT) rescanning during treatment. An adaptive score (AS) was proposed to guide ART decisions based on changes in four dose indices: target coverage, spinal cord dose, parotid gland dose, and over-dose volume. Delivered dose distributions were reviewed by two head and neck radiation oncologists, with ART requirement evaluated using a four-point scale. Logistic regression determined the AS cutoff, while receiver operating characteristic analysis assessed 2DWET as a predictor of ART timing.</p><p><strong>Results: </strong>The AS strongly correlated with the oncologists' ART decisions (Pearson coefficients of 0.74 and 0.64). An AS cutoff of 7.5 optimally indicated ART requirement, matching oncologist decisions with sensitivities of 79.2% and 89.5%, and specificities of 87.5% and 81.0%, respectively. The 2DWET method identified the AS threshold of 7.5 with sensitivity and specificity of 63.2% and 81.0%.</p><p><strong>Conclusion: </strong>An AS of 7.5 was highly indicative of ART timing, aligning well with oncologists' decisions, and 2DWET demonstrated potential as a low-exposure, efficient tool for predicting ART timing in patients with oropharyngeal and hypopharyngeal cancers.</p>","PeriodicalId":8072,"journal":{"name":"Anticancer research","volume":"45 1","pages":"387-397"},"PeriodicalIF":1.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anticancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/anticanres.17427","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background/aim: This study aimed to predict the optimal timing for adaptive radiation therapy (ART) using two-dimensional X-ray image-based water equivalent thickness (2DWET).

Patients and methods: Forty patients with oropharyngeal and hypopharyngeal cancer underwent Computed Tomography (CT) rescanning during treatment. An adaptive score (AS) was proposed to guide ART decisions based on changes in four dose indices: target coverage, spinal cord dose, parotid gland dose, and over-dose volume. Delivered dose distributions were reviewed by two head and neck radiation oncologists, with ART requirement evaluated using a four-point scale. Logistic regression determined the AS cutoff, while receiver operating characteristic analysis assessed 2DWET as a predictor of ART timing.

Results: The AS strongly correlated with the oncologists' ART decisions (Pearson coefficients of 0.74 and 0.64). An AS cutoff of 7.5 optimally indicated ART requirement, matching oncologist decisions with sensitivities of 79.2% and 89.5%, and specificities of 87.5% and 81.0%, respectively. The 2DWET method identified the AS threshold of 7.5 with sensitivity and specificity of 63.2% and 81.0%.

Conclusion: An AS of 7.5 was highly indicative of ART timing, aligning well with oncologists' decisions, and 2DWET demonstrated potential as a low-exposure, efficient tool for predicting ART timing in patients with oropharyngeal and hypopharyngeal cancers.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于二维x射线图像的水等效厚度预测和监测适应性放射治疗时机。
背景/目的:本研究旨在利用基于二维x射线图像的水当量厚度(2DWET)预测适应性放射治疗(ART)的最佳时机。患者和方法:40例口咽癌和下咽癌患者在治疗期间进行了计算机断层扫描。根据靶覆盖、脊髓剂量、腮腺剂量和过量体积这四个剂量指标的变化,提出了一个自适应评分(AS)来指导ART决策。递送剂量分布由两位头颈部放射肿瘤学家审查,ART需求采用四分制评估。逻辑回归确定AS截止,而接受者工作特征分析评估2DWET作为ART时间的预测因子。结果:AS与肿瘤学家的ART决策密切相关(Pearson系数分别为0.74和0.64)。AS临界值为7.5,最佳提示ART需求,与肿瘤学家的决定相匹配,敏感性分别为79.2%和89.5%,特异性分别为87.5%和81.0%。2DWET法检测AS阈值为7.5,灵敏度为63.2%,特异度为81.0%。结论:AS为7.5是ART时机的高度指示,与肿瘤学家的决定很好地一致,2DWET显示出作为预测口咽癌和下咽癌患者ART时机的低暴露、有效工具的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Anticancer research
Anticancer research 医学-肿瘤学
CiteScore
3.70
自引率
10.00%
发文量
566
审稿时长
2 months
期刊介绍: ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed. ANTICANCER RESEARCH was established in 1981 and is published monthly (bimonthly until the end of 2008). Each annual volume contains twelve issues and index. Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies). Special issues, presenting the proceedings of meetings or groups of papers on topics of significant progress, will also be included in each volume. There is no limitation to the number of pages per issue.
期刊最新文献
Comparing Immuno-oncology Combination Therapy With Tyrosine Kinase Inhibitor Monotherapy for Advanced Renal Cell Carcinoma. Comparison of Cell-death Kinetics of Recombinant Methioninase (rMETase)-treated Cancer and Normal Cells: Only Cancer Cells Undergo Methionine-depletion Catastrophe at Low rMETase Concentrations. Circulating Pre-microRNA-488 in Blood Is a Potential Prognostic Biomarker in Gastric Cancer. Corrigenda. Development of a Prognostic Model for Stage IV Colorectal Cancer Using Metastatic Patterns.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1